FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to the compound of the formula (I) and pharmaceutically acceptable acid-additive salts where A means N or CH; B means -NT1R2,-NHCHR1R2,-OCHR1R2. Compounds show an antagonistic activity with respect to corticotropin-releasing factor (CRF). It is known that CRF-antagonists are effective for treatment of broad spectrum of diseases caused by stress, for example, depression, fear, headache, irritable bowel syndrome, inflammatory diseases, immunity attenuation, Alzheimer's disease, gastroenteric diseases, neurotic anorexia, hemorrhagic stress, abstinent syndrome of drug and alcohol withdrawal, addiction to excess use of drugs and sterility. EFFECT: enhanced effectiveness of compounds. 7 cl, 1 tbl, 8 ex
Authors
Dates
1999-08-27—Published
1995-05-18—Filed